✦ LIBER ✦

Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial

✍ Scribed by Edward S Kim; Vera Hirsh; Tony Mok; Mark A Socinski; Radj Gervais; Yi-Long Wu; Long-Yun Li; Claire L Watkins; Mark V Sellers; Elizabeth S Lowe; Yan Sun; Mei-Lin Liao; Kell Østerlind; Martin Reck; Alison A Armour; Frances A Shepherd; Scott M Lippman; Jean-Yves Douillard

Book ID: 117303958
Publisher: The Lancet
Year: 2008
Tongue: English
Weight: 243 KB
Volume: 372
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(08)61758-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Molecular Predictors of Outcome With Gef

Molecular Predictors of Outcome With Gefitinib and Docetaxel in Previously Treated Non-Small-Cell Lung Cancer: Data From the Randomized Phase III INTEREST Trial

✍ Douillard, J.-Y.; Shepherd, F. A.; Hirsh, V.; Mok, T.; Socinski, M. A.; Gervais, 📂 Article 📅 2010 🏛 American Society of Clinical Oncology 🌐 English ⚖ 241 KB

Randomized Phase III Trial of Pemetrexed

Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non-Small-Cell Lung Cancer Previously Treated With Chemotherapy

✍ Hanna, N.; Shepherd, F. A.; Fossella, F. V.; Pereira, J. R.; De Marinis, F.; von 📂 Article 📅 2004 🏛 American Society of Clinical Oncology 🌐 English ⚖ 229 KB

Review of two phase III randomized trial

Review of two phase III randomized trials of single-agent docetaxel in previously treated advanced non-small cell lung cancer

✍ Thomas J Lynch Jr 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 515 KB

Phase II and Phase III Trials: Docetaxel

Phase II and Phase III Trials: Docetaxel/Irinotecan versus Docetaxel/Cisplatin in Advanced Non–Small-Cell Lung Cancer (WJTOG 9803)

📂 Article 📅 2001 🏛 CIG Media Group, LP. 🌐 English ⚖ 70 KB

A randomised phase II study of docetaxel

A randomised phase II study of docetaxel/oxaliplatin and docetaxel in patients with previously treated non-small cell lung cancer: An Alpe–Adria Thoracic Oncology Multidisciplinary group trial (ATOM 019)

✍ Ornella Belvedere; Alessandro Follador; Ciro Rossetto; Valentina Merlo; Carlotta 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 249 KB

Concurrent celecoxib versus placebo in p

Concurrent celecoxib versus placebo in patients with stage II–III non-small cell lung cancer: A randomised phase II trial

✍ Dirk De Ruysscher; Johan Bussink; Patrick Rodrigus; Alfons Kessels; Miranda Dirx 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 52 KB